RAB6D

gene
On this page

Also known as RAB6CLWTH3DI

Summary

RAB6D (RAB6D, member RAS oncogene family, HGNC:30272) is a protein-coding gene on chromosome 2q21.1, encoding Ras-related protein Rab-6D (Q53S08). The small GTPases Rab are key regulators of intracellular membrane trafficking, from the formation of transport vesicles to their fusion with membranes.

Predicted to enable GTPase activity. Predicted to be involved in several processes, including Golgi vesicle transport; protein localization to Golgi membrane; and retrograde transport, endosome to Golgi. Located in Golgi apparatus; ciliary basal body; and nucleoplasm.

Source: NCBI Gene 150786 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 2 total
  • MANE Select transcript: NM_001077637

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:30272
Approved symbolRAB6D
NameRAB6D, member RAS oncogene family
Location2q21.1
Locus typegene with protein product
StatusApproved
AliasesRAB6CL, WTH3DI
Ensembl geneENSG00000233087
Ensembl biotypeprotein_coding
Entrez150786

Gene structure

Transcript identifiers

Ensembl transcripts: 1 — 1 protein_coding

ENST00000623617

RefSeq mRNA: 1 — MANE Select: NM_001077637 NM_001077637

CCDS: CCDS82514

Canonical transcript exons

ENST00000623617 — 1 exons

ExonStartEnd
ENSE00003758111131360492131364168

Expression profiles

Bgee: expression breadth broad, 62 present calls, max score 75.45.

Top tissues by expression

120 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047375.45gold quality
superior frontal gyrusUBERON:000266164.63gold quality
quadriceps femorisUBERON:000137764.14gold quality
prefrontal cortexUBERON:000045164.08gold quality
cerebellar vermisUBERON:000472063.05gold quality
cortical plateUBERON:000534361.25gold quality
primary visual cortexUBERON:000243661.08gold quality
rectumUBERON:000105260.15gold quality
frontal cortexUBERON:000187058.80gold quality
Brodmann (1909) area 9UBERON:001354058.10gold quality
thymusUBERON:000237057.37silver quality
dorsolateral prefrontal cortexUBERON:000983457.20gold quality
cerebral cortexUBERON:000095656.76gold quality
islet of LangerhansUBERON:000000656.66gold quality
hypothalamusUBERON:000189854.95gold quality
prostate glandUBERON:000236754.45gold quality
anterior cingulate cortexUBERON:000983553.43gold quality
transverse colonUBERON:000115753.37gold quality
Ammon’s hornUBERON:000195452.92gold quality
ventricular zoneUBERON:000305352.20silver quality
nucleus accumbensUBERON:000188251.91gold quality
right frontal lobeUBERON:000281050.26gold quality
smooth muscle tissueUBERON:000113549.80gold quality
temporal lobeUBERON:000187149.65gold quality
duodenumUBERON:000211449.62gold quality
amygdalaUBERON:000187649.45gold quality
caudate nucleusUBERON:000187349.34gold quality
small intestineUBERON:000210849.29gold quality
gall bladderUBERON:000211049.11gold quality
stromal cell of endometriumCL:000225548.88gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes8.81

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

115 targeting RAB6D, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-LET-7A-3P100.0074.033932
HSA-LET-7B-3P100.0074.083913
HSA-LET-7F-1-3P100.0074.023928
HSA-MIR-98-3P100.0074.083907
HSA-MIR-340-5P100.0072.504437
HSA-MIR-6867-5P100.0082.213464
HSA-MIR-4768-5P100.0069.492861
HSA-MIR-6833-3P100.0070.633197
HSA-MIR-190A-3P100.0080.355520
HSA-MIR-5692A100.0074.406850
HSA-MIR-186-5P99.9970.833707
HSA-MIR-806899.9873.852376
HSA-MIR-477599.9875.006394
HSA-MIR-1213699.9872.815713
HSA-MIR-570-3P99.9672.414910
HSA-MIR-590-3P99.9674.346478
HSA-MIR-4666A-3P99.9671.713434
HSA-MIR-391099.9571.132227
HSA-MIR-6835-3P99.9370.492904
HSA-MIR-314399.9371.963104
HSA-MIR-311999.9271.342390
HSA-MIR-130599.9171.433443
HSA-MIR-219A-5P99.9173.36735
HSA-MIR-368699.9070.532432
HSA-MIR-6499-3P99.9066.381212
HSA-MIR-548E-5P99.8972.734486
HSA-MIR-4782-3P99.8873.31735
HSA-MIR-6766-3P99.8873.38732
HSA-MIR-612499.8769.783551
HSA-MIR-369-3P99.8570.522264

Cross-species orthologs

0 orthologs

Paralogs (68): RAB27B (ENSG00000041353), RAB27A (ENSG00000069974), RAB7A (ENSG00000075785), RABL2B (ENSG00000079974), RAB21 (ENSG00000080371), RAB10 (ENSG00000084733), RAB18 (ENSG00000099246), RAB36 (ENSG00000100228), IFT27 (ENSG00000100360), RAB40AL (ENSG00000102128), RAB11A (ENSG00000103769), RAB2A (ENSG00000104388), RAB3D (ENSG00000105514), RAB3A (ENSG00000105649), RAB5C (ENSG00000108774), RAB34 (ENSG00000109113), RAB5B (ENSG00000111540), RAB35 (ENSG00000111737), RAB23 (ENSG00000112210), DNAJC27 (ENSG00000115137), RAB29 (ENSG00000117280), RAB32 (ENSG00000118508), RAB14 (ENSG00000119396), RAB9B (ENSG00000123570), RAB9A (ENSG00000123595), RAB38 (ENSG00000123892), RAB22A (ENSG00000124209), RAB17 (ENSG00000124839), RAB2B (ENSG00000129472), RAB25 (ENSG00000132698), RAB33A (ENSG00000134594), RAB30 (ENSG00000137502), RAB1A (ENSG00000138069), RAB20 (ENSG00000139832), RAB15 (ENSG00000139998), RAB40B (ENSG00000141542), RAB13 (ENSG00000143545), RABL2A (ENSG00000144134), RAB5A (ENSG00000144566), RAB19 (ENSG00000146955)

Protein

Protein identifiers

Ras-related protein Rab-6DQ53S08 (reviewed: Q53S08)

Alternative names: Rab6-like protein WTH3DI

All UniProt accessions (1): Q53S08

UniProt curated annotations — full annotation on UniProt →

Function. The small GTPases Rab are key regulators of intracellular membrane trafficking, from the formation of transport vesicles to their fusion with membranes. Rabs cycle between an inactive GDP-bound form and an active GTP-bound form that is able to recruit to membranes different sets of downstream effectors directly responsible for vesicle formation, movement, tethering and fusion.

Domain organisation. Switch 1, switch 2 and the interswitch regions are characteristic of Rab GTPases and mediate the interactions with Rab downstream effectors. The switch regions undergo conformational changes upon nucleotide binding which drives interaction with specific sets of effector proteins, with most effectors only binding to GTP-bound Rab.

Similarity. Belongs to the small GTPase superfamily. Rab family.

RefSeq proteins (1): NP_001071105* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR001806Small_GTPaseFamily
IPR005225Small_GTP-bdDomain
IPR027417P-loop_NTPaseHomologous_superfamily
IPR050227RabFamily

Pfam: PF00071

Catalyzed reactions (Rhea), 1 shown:

  • GTP + H2O = GDP + phosphate + H(+) (RHEA:19669)

UniProt features (20 total): binding site 17, short sequence motif 2, chain 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q53S08-F173.660.45

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Ligand- & substrate-binding residues (17): 39; 40; 42; 68; 71; 126; 127; 129; 157; 158; 23; 24

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 57 (showing top): GOBP_INTRACELLULAR_PROTEIN_TRANSPORT, GOBP_VESICLE_MEDIATED_TRANSPORT, GOCC_MICROTUBULE_ORGANIZING_CENTER, GOBP_INTRA_GOLGI_VESICLE_MEDIATED_TRANSPORT, GOBP_PROTEIN_LOCALIZATION_TO_GOLGI_APPARATUS, GOBP_PROTEIN_LOCALIZATION_TO_ORGANELLE, GOBP_RETROGRADE_TRANSPORT_ENDOSOME_TO_GOLGI, GOBP_LOCALIZATION_WITHIN_MEMBRANE, GOBP_CYTOSOLIC_TRANSPORT, GOCC_CILIUM, GOCC_CILIARY_BASAL_BODY, GOMF_GTPASE_ACTIVITY, GOBP_GOLGI_VESICLE_TRANSPORT, GOMF_HYDROLASE_ACTIVITY_ACTING_ON_ACID_ANHYDRIDES, GOBP_RETROGRADE_VESICLE_MEDIATED_TRANSPORT_GOLGI_TO_ENDOPLASMIC_RETICULUM

GO Biological Process (5): intracellular protein transport (GO:0006886), retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890), intra-Golgi vesicle-mediated transport (GO:0006891), retrograde transport, endosome to Golgi (GO:0042147), protein localization to Golgi membrane (GO:1903292)

GO Molecular Function (6): GTPase activity (GO:0003924), G protein activity (GO:0003925), GTP binding (GO:0005525), metal ion binding (GO:0046872), nucleotide binding (GO:0000166), hydrolase activity (GO:0016787)

GO Cellular Component (5): nucleoplasm (GO:0005654), Golgi apparatus (GO:0005794), cytosol (GO:0005829), endomembrane system (GO:0012505), ciliary basal body (GO:0036064)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cellular anatomical structure3
Golgi vesicle transport2
cytoplasm2
intracellular protein localization1
protein transport1
intracellular transport1
intercellular transport1
endosomal transport1
cytosolic transport1
protein localization to Golgi apparatus1
protein localization to membrane1
ribonucleoside triphosphate phosphatase activity1
GTPase activity1
molecular function regulator activity1
guanyl ribonucleotide binding1
purine ribonucleoside triphosphate binding1
cation binding1
nucleoside phosphate binding1
heterocyclic compound binding1
catalytic activity1
nuclear lumen1
endomembrane system1
intracellular membrane-bounded organelle1
vacuole1
plasma membrane1
microtubule organizing center1
cilium1

Protein interactions and networks

STRING

330 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
RAB6DSCFD1Q8WVM8611
RAB6DGDI2P50395609
RAB6DUSO1O60763597
RAB6DRAB1AP11476402
RAB6DRAB7AP51149400
RAB6DRAB6AP20340364
RAB6DDCTN6O00399325
RAB6DA1CFQ9NQ94292
RAB6DRINT1Q6NUQ1277
RAB6DSTX8Q9UNK0277
RAB6DSYNGR1O43759269
RAB6DRBM47A0AV96256
RAB6DPIRTP0C851246
RAB6DRTCBQ9Y3I0244
RAB6DKIF18AQ8NI77222

IntAct

8 interactions, top by confidence:

ABTypeScore
SLC12A4LGALS3psi-mi:“MI:0914”(association)0.530
RIN3psi-mi:“MI:0914”(association)0.350
RAB6CCAPSpsi-mi:“MI:0914”(association)0.350
SLC10A1FLOT1psi-mi:“MI:0914”(association)0.350
SLC12A6SCAMP1psi-mi:“MI:0914”(association)0.350
SLC2A3NRP2psi-mi:“MI:0914”(association)0.350
CFTRUBA6psi-mi:“MI:2364”(proximity)0.270

BioGRID (9): WTH3DI (Affinity Capture-MS), WTH3DI (Affinity Capture-MS), WTH3DI (Affinity Capture-MS), WTH3DI (Affinity Capture-MS), WTH3DI (Cross-Linking-MS (XL-MS)), WTH3DI (Affinity Capture-MS), WTH3DI (Affinity Capture-MS), WTH3DI (Affinity Capture-MS), WTH3DI (Proximity Label-MS)

ESM2 similar proteins: A2YEQ6, O35963, O74536, O95661, O95755, P25378, P35283, P35284, P51156, P52198, P97950, Q00246, Q02723, Q06AU4, Q08AT1, Q08E00, Q09178, Q14088, Q20365, Q29RR0, Q3SXC5, Q3UHC2, Q504M8, Q53S08, Q5H913, Q5JT25, Q5R615, Q5U1Y1, Q5ZHV1, Q62120, Q62689, Q64008, Q69XM7, Q6IQ22, Q75R65, Q7SZ59, Q7TN89, Q7Z444, Q8C0V7, Q8CAM5

Diamond homologs: A4FV54, A6QR46, M0RC99, O18333, O18334, O80501, P05712, P11023, P16976, P17608, P18066, P20336, P20339, P20340, P22127, P22128, P24409, P25228, P29687, P31582, P31583, P34213, P35276, P35278, P35279, P35280, P35292, P36017, P36586, P36863, P49103, P49104, P51147, P51148, P53994, P55258, P61006, P61007, P61019, P61020

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

2 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance2
Likely benign0
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

0 predictions. Top by Δscore:

AlphaMissense

1655 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
2:131363265:A:CF152L0.877
2:131363265:A:TF152L0.877
2:131363267:A:GF152L0.877
2:131363418:G:CF101L0.849
2:131363418:G:TF101L0.849
2:131363420:A:GF101L0.849
2:131363679:G:CF14L0.844
2:131363679:G:TF14L0.844
2:131363681:A:GF14L0.844
2:131363622:G:CF33L0.830
2:131363622:G:TF33L0.830
2:131363624:A:GF33L0.830
2:131363220:A:CF167L0.779
2:131363220:A:TF167L0.779
2:131363222:A:GF167L0.779
2:131363667:G:CF18L0.777
2:131363667:G:TF18L0.777
2:131363669:A:GF18L0.777
2:131363607:A:CF38L0.762
2:131363607:A:TF38L0.762
2:131363609:A:GF38L0.762
2:131363571:A:CF50L0.724
2:131363571:A:TF50L0.724
2:131363573:A:GF50L0.724
2:131363288:C:GA145P0.682
2:131363400:C:AW107C0.656
2:131363400:C:GW107C0.656
2:131363402:A:GW107R0.648
2:131363402:A:TW107R0.648
2:131363259:T:AE154D0.635

dbSNP variants (sampled 300 via entrez): RS1003672153 (2:131364083 G>A,C,T), RS1005653017 (2:131361270 C>T), RS1006169203 (2:131366058 TAAAG>T), RS1006614204 (2:131365883 T>TA), RS1007510626 (2:131360480 TCAAA>T), RS1007536705 (2:131360141 G>A), RS1007580529 (2:131361940 A>C,G), RS1008538129 (2:131361773 T>C), RS1010054361 (2:131362061 GT>G), RS1010437267 (2:131362420 A>G), RS1010720708 (2:131365176 C>T), RS1012041642 (2:131365862 A>G), RS1014675223 (2:131361233 TA>T), RS1014952551 (2:131365886 A>G), RS1015397618 (2:131365743 C>A,T)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

11 total (human), top 11 by PubMed support.

ChemicalActions (top 5)PubMed papers
FR900359increases phosphorylation1
bisphenol Adecreases expression1
sodium arseniteaffects cotreatment, increases expression1
ferrous chloridedecreases expression1
Resveratrolaffects cotreatment, decreases expression1
Benzo(a)pyreneaffects methylation, increases methylation1
Copperaffects cotreatment, decreases expression1
Doxorubicindecreases expression1
Tretinoinincreases expression, affects cotreatment1
Aflatoxin B1decreases methylation1
Okadaic Acidincreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.